Flutin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flutin

Quick Facts about Flutin

Property Description
Active ingredient Fluoxetine (as Hydrochloride salt)
Form Capsule, Tablet, Oral solution
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common use Modulation of mood and emotional stability
Origin Synthetic compound

What Type of Medicine is Flutin and What is its Composition?

Flutin is a synthetic prescription-only medicine classified as a Psychotropic agent, with the active ingredient being Fluoxetine Hydrochloride (the salt form of Fluoxetine). This compound is specifically classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Pharmacological studies confirm that Fluoxetine and its active metabolite, norfluoxetine, possess a long elimination half-life, which is a distinguishing feature compared to many other SSRIs. The patient can understand this means the active substance persists in the body for an extended period after chronic use. Flutin is supplied for oral administration as a single active ingredient product in standard dosage forms, including a solid capsule, a tablet, and an oral solution.

How Does Fluoxetine Work at a Basic Level?

Fluoxetine primarily works by modulating the brain’s chemical environment through a process called serotonin reuptake blockade. This fundamental action, characteristic of the SSRI class, prevents the reabsorption of the monoamine neurotransmitter serotonin back into the nerve cell, consequently increasing its available concentration in the synaptic space. This activity on the serotonin system provides the mechanism for its therapeutic effects. The general purpose of this action is to help restore a better chemical balance necessary for regulating emotional responses. This supported modulation of the serotonin system supports the body’s innate ability to regulate emotion, stabilize pervasive mood issues, and promote psychological stability over time.

Regulatory References

  1. NIH StatPearls Fluoxetine

What side effects are possible with Flutin?

Possible Side Effects and Safety Information

The safety profile of Flutin (Fluoxetine) is formally categorized by regulatory authorities, distinguishing between frequent, less frequent, and serious adverse reactions.

Adverse reactions are classified by the frequency of occurrence and the System Organ Class (SOC) affected. Officially documented Very Common (ge 1 in 10 patients) effects include Headache, Insomnia, Diarrhea, Nausea, and Fatigue (asthenia). Common (ge 1 in 100 to < 1 in 10 patients) reactions often affect the Nervous and Psychiatric Systems, such as anxiety, tremor, and decreased libido.

Serious adverse reactions are documented in official safety information. These include the risk of Serotonin Syndrome (a potentially life-threatening condition), rare reports of Hepatotoxicity (liver injury), and the possibility of Serious Hypersensitivity reactions, such as Stevens-Johnson syndrome. The official labels also contain warnings regarding the increased risk of Suicidal Thoughts and Behavior in children, adolescents, and young adults, particularly during the initial months of treatment and following dosage changes.

Safety notes for specific populations exist. For example, older adults may be at a greater risk of developing Hyponatraemia (low sodium concentration). Furthermore, the drug's classification as a Selective Serotonin Reuptake Inhibitor (SSRI) means it is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs) due to the high risk of serious reactions, a key safety restriction documented in regulatory prescribing information. The long elimination half-life is an important safety characteristic, as the active substance persists in the body for an extended period after cessation of chronic use.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Flutin, or its active ingredient Fluoxetine, may present with a spectrum of officially documented central nervous system and systemic manifestations. The most commonly reported signs in regulatory labeling include nausea, vomiting, significant drowsiness (somnolence), and tremor. Severe presentations documented in official sources can involve more serious neurological events such as seizures, stupor, and coma. Cardiovascular toxicity is a major concern, manifesting as tachycardia (fast heart rate) and QT interval prolongation, which can lead to life-threatening ventricular arrhythmia like Torsades de Pointes.

Immediate medical attention is mandated for any suspected overdose or for the rapid onset of severe signs. The official profile states that no specific antidote is known for Fluoxetine overdose. Management, therefore, consists solely of general symptomatic and supportive treatment measures. Authorities advise that prolonged observation and continuous ECG monitoring are necessary due to the drug's long elimination half-life, which prolongs the risk of delayed toxicity. Regulatory documents note that co-ingestion with other serotonergic agents significantly increases the risk for the severe complication known as Serotonin Syndrome.

Therapeutic Uses of Flutin

What Flutin Treats: Main Uses and Benefits

Flutin may be relevant in clinical settings that involve acute or unstable symptom patterns, and can be applied across domains where additional symptomatic support is needed. It is commonly used across conditions characterized by periods of heightened symptoms, including Major Depressive Disorder (MDD), Obsessive-Compulsive Disorder (OCD), Bulimia Nervosa, Panic Disorder, and Premenstrual Dysphoric Disorder (PMDD). It is generally applied during phases when symptoms become more noticeable, where supportive symptom management is appropriate.

The medication is commonly used to help with symptom clusters related to pervasive low mood, intrusive thoughts, and behavioral dyscontrol. It contributes to easing the overall symptom load, which may help patients cope more steadily with symptom fluctuations.

“It is commonly used when short-term symptomatic assistance is needed and supports general well-being during symptomatic phases.”

Quick Fact: Symptomatic Relief Domains
Support for Mood May assist with persistent low mood and loss of interest (anhedonia).
Support for Anxiety Is used for managing unwanted, recurring thoughts and panic attacks.
Assistance with Behavior Contributes to easing the frequency of binge-eating and purging.

Regulatory References

  1. NIH MedlinePlus overview on Fluoxetine

Eligibility and Restrictions for Use

Official Eligibility Profile for Flutin

The eligibility criteria for Flutin (Fluoxetine) are based strictly on regulatory safety and effectiveness profiles, establishing clear rules for use.


Absolute Contraindications

Patients must not use Flutin if they have a known hypersensitivity to any component of the medication. It is strictly contraindicated for patients who are currently taking a psychiatric Monoamine Oxidase Inhibitor (MAOI), Pimozide, Thioridazine, or intravenous Methylene Blue. Regulatory requirements mandate specific washout periods when transitioning between these medications.


Age-Group Eligibility

Population Approved Status (by Indication)
Adults (18+) Eligible for all approved uses.
Pediatric (7–17) Established for OCD (ages 7+) and MDD (ages 8+).
Children (<7 or <8) Use is not established for these younger age groups.

Conditional Use and Restrictions

Use requires explicit caution in patients with a history of seizures or conditions that predispose to QT prolongation (a heart-rhythm abnormality). Individuals with hepatic impairment (liver cirrhosis) are eligible but require a lower or less frequent dose due to the drug's significantly prolonged elimination time. Use also requires caution for those with risk factors for angle-closure glaucoma. Breastfeeding is not recommended, and use during pregnancy is advised only if the potential benefit explicitly outweighs the potential risk to the fetus, as documented in regulatory guidelines.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Flutin's official interaction profile is characterized by two major mechanisms: its potent inhibitory effect on the CYP2D6 enzyme and its serotonergic activity.

Contraindicated Combinations and Serotonergic Risk

Use with certain medicines is strictly prohibited due to significant safety risks. These include all Monoamine Oxidase Inhibitors (MAOIs) intended for psychiatric treatment, which are contraindicated due to the risk of severe Serotonin Syndrome. A mandatory washout period of 14 days is required when switching from an MAOI to Flutin, and 5 weeks when switching from Flutin to an MAOI. The combination with Pimozide or Thioridazine is also contraindicated because of the heightened risk of QTc prolongation and potential cardiac toxicity. The co-administration of Flutin with other serotonergic agents—such as Triptans, Tricyclic Antidepressants, Fentanyl, Lithium, Tramadol, or St. John's Wort—must be approached with caution due to the possibility of Serotonin Syndrome.

Pharmacokinetic and Bleeding Risk

As a potent inhibitor of the CYP2D6 enzyme, Flutin can significantly increase the plasma levels of co-administered drugs metabolized by this pathway, including certain Antipsychotics (e.g., Haloperidol, Clozapine), Tricyclic Antidepressants, and Anticonvulsants (e.g., Phenytoin, Carbamazepine), requiring careful monitoring. Furthermore, combining Flutin with drugs that interfere with hemostasis, such as NSAIDs, Aspirin, or Warfarin, may potentiate the risk of abnormal bleeding. Separately, for a non-opioid analgesic product also known as Flutin (Flupirtine), concurrent use is contraindicated with other medicines causing liver problems or in patients with pre-existing liver disease, with use limited to a maximum of 2 weeks.

Mechanism of Action

How Flutin Works

Flutin’s mechanism of action is primarily executed through the active ingredient, Fluoxetine, a selective inhibitor of the Serotonin Transporter ( SERT) protein on presynaptic nerve terminals. This interaction is highly specific and operates within the central serotonergic system.

The immediate molecular consequence is the selective blockade of 5-HT ( serotonin) reuptake from the synaptic cleft, resulting in an acute rise in 5-HT concentration. This action initiates a crucial, time-dependent mechanistic cascade.

Chronic SERT inhibition leads to a slower, adaptive physiological shift characterized by the downregulation or desensitization of presynaptic 5-HT autoreceptors. This reduces the negative feedback mechanism, leading to a functional boost in 5-HT signaling efficiency over a period of weeks. The sustained alteration in neurotransmission promotes neuroplasticity and functional reorganization within regulatory neural pathways. A secondary action involves the inhibition of specific hepatic CYP enzymes ( CYP2D6), representing a parallel enzymatic consequence within the body.

Dosage and Administration Information

How to Use Flutin

Flutin (Fluoxetine) is administered exclusively through the oral route across all its approved dosage forms, which include capsules, tablets, and an oral solution. The medicine may be taken with or without food, as administration timing relative to meals does not impact its absorption. Dosing is usually recommended for the morning hours.

Official Dosing and Frequency

Standard dosing varies by the approved condition. For Major Depressive Disorder (MDD), the typical adult starting dose is 20 mg once daily, with maintenance doses usually ranging from 20 mg to 60 mg per day. The maximum recommended daily dose for most indications is 80 mg. While most regimens are once daily, total daily doses exceeding 20 mg may be split into two divided doses (morning and noon).

Flutin also comes in a 90 mg delayed-release capsule designed for a once-weekly administration pattern. When transitioning from the daily immediate-release form to the weekly capsule, there is a 7-day interval after the last daily dose before initiating the weekly schedule.

Population and Procedural Adjustments

For older adults, the daily dose is typically limited and generally should not exceed 40 mg. Patients with known hepatic impairment (liver issues) require specific consideration for a lower or less frequent dosing schedule due to decreased clearance. If the oral solution is used, it must be accurately measured using a calibrated device to ensure precise dosing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flutin (Fluoxetine)

This overview summarizes the official research evidence, primarily from randomized controlled trials (RCTs) and systematic reviews, as reported in authoritative governmental sources. It describes what was studied, the types of findings reported, and what remains uncertain in the research landscape.


Evidence for Use in Major Depressive Disorder (MDD)

Fluoxetine was studied for the management of MDD in large populations of adults, children, and adolescents. The core evidence comes from numerous short-term, placebo-controlled RCTs, which typically research explored how symptoms change over periods of 5 to 13 weeks. For acute treatment, findings describe patterns where the outcomes measured in treated groups described patterns in final symptom measurements that differed from groups receiving placebo. However, some large-scale scientific reviews suggest that the reported measurement changes compared to placebo are modest.

Evidence regarding the durability of the measured effect was explored in maintenance trials. These studies monitor the rate of symptom recurrence over periods ranging from six months to a year.

Evidence for Use in Obsessive-Compulsive Disorder (OCD)

The research for OCD was evaluated in specific short-term, placebo-controlled RCTs involving both adults and children/adolescents. Studies monitored outcomes related to episodic or acute changes in obsessions and compulsions. Research describes that the dosage studied in these trials was observed in some studies to be greater for observing change in OCD symptoms than for MDD symptoms.

Evidence in Other Clinical Contexts

Research for Bulimia Nervosa primarily consists of short-term, placebo-controlled RCTs, which focused on the frequency of binge-eating episodes and purging behaviors. For Panic Disorder, research was evaluated in short-term RCTs typically lasting 10 to 12 weeks, specifically tracking the frequency of panic attacks.


What Is Still Uncertain about the Research Base

Official reviews highlight limitations in the research landscape. The consistency of evidence varies across studies, and follow-up durations were limited in many key trials. Subgroup findings are uncertain for many groups not well-represented in the original RCTs. Research provides context but not individual predictions about a personal outcome.

Key Studies & References

  1. Fluoxetine - StatPearls [Internet]: Clinical uses, Dosing, and Evidence Summary
  2. Fluoxetine: MedlinePlus Drug Information - National Institutes of Health (NIH)
  3. Fluoxetine: Efficacy in Major Depressive Disorder, Obsessive Compulsive Disorder, and Panic Disorder

Frequently Asked Questions (FAQ)

Common questions about Flutin (FAQ)


Q: What is Flutin used for besides its main approved purpose?

A: According to official prescribing information, Flutin is approved for several conditions beyond its use in Major Depressive Disorder (MDD) and Obsessive Compulsive Disorder (OCD). It is also approved for conditions such as Bulimia Nervosa and Panic Disorder. Furthermore, it is approved for use in combination with olanzapine to treat depressive episodes associated with Bipolar I Disorder and Treatment Resistant Depression.

Q: What happens if I stop taking Flutin suddenly?

A: Regulatory documents advise against abruptly stopping this medication. This is because sudden cessation may lead to discontinuation symptoms, which can include dizziness, anxiety, and sensory disturbances. Regulatory agencies advise that the prescribed treatment plan, including discontinuation, should be followed carefully.

Q: What are the long-term effects of taking Flutin?

A: Official product labeling notes that the effectiveness and safety of the drug for very long periods (such as more than several months) have not been systematically evaluated in long-term placebo-controlled trials. Due to this, ongoing regulatory guidance emphasizes that the medication's need and effectiveness should be re-evaluated periodically during long-term use.

Q: Does Flutin expire?

A: Yes, like all prescription drugs, Flutin has a regulatory-mandated expiration date printed on the packaging. The expiration date helps ensure the medication maintains its chemical stability and expected potency.

Q: What should I do if I have an allergic reaction to Flutin?

A: In the event of severe symptoms that may indicate a serious allergic reaction, such as swelling, rash, or difficulty breathing, regulatory information advises seeking immediate consultation with a healthcare professional or emergency medical attention. Regulatory documents specifically warn about the possibility of serious hypersensitivity reactions.

Q: What kind of monitoring is needed while on Flutin?

A: Official regulatory warnings highlight several safety conditions that require monitoring during treatment. These include watching for the emergence of suicidal thoughts and behaviors, signs of Serotonin Syndrome, and potential changes in heart rhythm, known as QTc prolongation. Patients are also monitored for the activation of mania or hypomania.

Q: Does Flutin lose its effectiveness over time?

A: Regulatory documentation discusses the importance of maintenance treatment in long-term care. It is noted that the effectiveness of the medication for extended use must be periodically re-evaluated by the prescribing healthcare provider as part of monitoring the long-term response.

Q: What does 'Black Box Warning' mean for Flutin?

A: A Boxed Warning, sometimes referred to as a Black Box Warning, is the most serious safety alert required by the FDA to call attention to specific severe risks. For this drug class, it highlights the increased risk of suicidal thinking and behavior, particularly in children, adolescents, and young adults.

Q: Can Flutin cause weight changes?

A: Official labeling indicates that altered appetite and weight changes may occur while taking this medication. This includes reports of both significant weight loss and significant weight gain.

Q: Can I take Flutin if I have high blood pressure?

A: High blood pressure (hypertension) is not listed as an absolute contraindication in regulatory documents. However, this drug is associated with a risk of an irregular heartbeat, or QTc prolongation, so caution is advised for patients with any pre-existing heart problems.

Q: What kinds of foods should I avoid while taking Flutin?

A: The official regulatory warnings for this prescription medicine do not typically include a list of specific foods that must be strictly avoided during treatment.

Q: Does alcohol interact with Flutin?

A: Yes, regulatory warnings advise that alcohol use should be avoided or limited during treatment. This is because combining the two can increase nervous system side effects such as dizziness, drowsiness, and difficulty concentrating.

Q: Is Flutin addictive or habit-forming?

A: No, the active ingredient in Flutin is not classified as a controlled substance by the DEA or similar international bodies. It is not considered to have physically addictive or abuse properties.

Q: Is Flutin available in a generic version?

A: Yes, the active ingredient, fluoxetine, is widely available in generic options. These generic options are available in various forms, including capsules, tablets, and oral solution.

Q: Does taking Flutin affect driving or operating machinery?

A: Official regulatory warnings advise that this medicine may cause impaired judgment, reduced coordination, or drowsiness in some people. Due to this risk, official information recommends patients wait until they know how the drug affects their individual abilities before driving or operating machinery.

Q: Can Flutin make me feel dizzy or lightheaded?

A: Yes, regulatory documents list both dizziness and somnolence (which means drowsiness) as common adverse reactions. These effects are often associated with the medication’s action on the central nervous system.

Q: Is there a warning about taking Flutin with grapefruit?

A: The official regulatory information for this drug does not contain a specific safety warning about an interaction with grapefruit or grapefruit juice.

Q: Is Flutin a controlled substance?

A: No, Flutin is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or other major international bodies.

Q: Can Flutin be taken by people with kidney issues?

A: While the official prescribing information emphasizes dose adjustments for patients with liver issues, specific dose adjustments are not typically required for severe kidney impairment. Regulatory documents recommend that the prescribing physician be made aware of any pre-existing kidney conditions.

Q: Can I share my Flutin prescription with someone else?

A: No. Regulatory safety information explicitly states that prescription medicine should never be shared with anyone else. Sharing a prescription may cause undesirable, potentially serious effects in the other person.

Q: What is the risk of overdose with Flutin?

A: Yes, overdose is possible. Regulatory documents state that symptoms can range from mild effects like headache and dry mouth to more severe issues like seizures and Serotonin Syndrome. If an overdose is suspected, regulatory information advises that immediate medical attention is necessary.

Q: Can Flutin cause dry mouth?

A: Yes, dry mouth (xerostomia) is explicitly listed as a common adverse reaction in the regulatory safety information for this drug.

How should Flutin be stored and disposed of?

Storage Conditions and Requirements

Flutin (Fluoxetine) must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product can tolerate temporary exposure to temperatures ranging from 15 C to 30 C (59 F to 86 F). To maintain stability, the medicine must be stored in its original container, kept tightly closed, and protected from excess heat, light, and moisture (such as in a bathroom).

As a mandatory safety requirement, the medication must always be stored out of the sight and reach of children.

Disposal Instructions

Official disposal protocols recommend utilizing a drug take-back program (e.g., pharmacy drop-off or mail-back envelope) as the preferred method for discarding unused or expired Fluoxetine. If a take-back option is unavailable, the medication can be mixed with an undesirable substance (like dirt or coffee grounds), placed in a sealed bag or container, and thrown into the household trash. It is explicitly stated that this medication should not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flutin found in:

A-Z Index: